6-K XBRL

FORM 6-K

Company: NYMOX PHARMACEUTICAL CORP
Filed: November 13, 2020
Period of Report: September 30, 2020
Accession Number: 0001640334-20-002804

View Document ↗ View on SEC.gov ↗